English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/84997
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:


Anti-inflammatory neuropeptide receptors: new therapeutic targets for immune disorders?

AuthorsGonzález-Rey, Elena; Delgado, M.
Issue Date2007
CitationTrends in Pharmacological Sciences 28: 482- 491 (2007)
AbstractThe loss of immune tolerance results in the breakdown of immune homeostasis and the appearance of exacerbated inflammatory conditions. Some anti-inflammatory neuropeptides have recently emerged as endogenous factors participating in the maintenance of immune tolerance. The effects of these neuropeptides in self-tolerance primarily depend on the activation of cAMP-protein kinase A signaling and the regulation of various transduction pathways involved in the expression of many immune factors. Understanding of the structure-function relationship of anti-inflammatory neuropeptides and their receptors will facilitate the development of novel pharmacological agents for the treatment of immune disorders. © 2007 Elsevier Ltd. All rights reserved.
Identifiersdoi: 10.1016/j.tips.2007.07.001
issn: 0165-6147
Appears in Collections:(IPBLN) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
Show full item record
Review this work

Related articles:

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.